Prof. Dr. med. Erwin P. Böttinger

CEO
Berlin Institute of Health (BIH)

Professor of Personalized Medicine
Charité Universitätsmedizin Berlin

Erwin P. Böttinger, MD, currently serves as Chief Executive Officer of the Berlin Institute of Health and as W3 Professor for Personalized Medicine at the Charité University Medicine in Berlin. Until October 2015 he was Director of The Charles Bronfman Institute for Personalized Medicine at the Icahn School of Medicine at Mount Sinai in New York City. Prof Böttinger established his independent research career at the Albert Einstein College of Medicine in New York where he held appointments as Associate Professor in Medicine and Molecular Genetics and established the Albert Einstein NIDDK Biotechnology Center. In 2004, he joined the Icahn School of Medicine at Mount Sinai as The Irene and Dr Arthur Fishberg Professor of Medicine and Professor of Pharmacology and Systems Therapeutics. Prof Böttinger served as Vice Chairman for Biomedical Research in the Department of Medicine and became the inaugural Director of The Charles Bronfman Institute for Personalized Medicine in 2007. Prof Böttinger is the Principal Investigator of Mount Sinai’s landmark BioMe hospital-based Biobank where electronic health records for over 30,000+ patients can be linked with their genomic and molecular marker datasets. Additionally, he served as Principal Investigator for several U.S. national research consortia on genomic medicine. As of April 2017, Prof Böttinger is also a member of the Einstein Center Digital Future (ECDF) Executive Board, filling the role as speaker in the section Digital Health.